Janus Henderson Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$346M Buy
2,880,199
+995,059
+53% +$115M 0.17% 136
2025
Q4
$198M Sell
1,885,140
-230,401
-11% -$21.6M 0.09% 196
2025
Q3
$178M Buy
2,115,541
+1,573,424
+290% +$130M 0.08% 200
2025
Q2
$42.9M Sell
542,117
-2,223,249
-80% -$177M 0.02% 424
2025
Q1
$247M Sell
2,765,366
-3,099,139
-53% -$289M 0.14% 167
2024
Q4
$583M Sell
5,864,505
-2,905,121
-33% -$300M 0.3% 75
2024
Q3
$996M Sell
8,769,626
-1,921,052
-18% -$228M 0.51% 34
2024
Q2
$1.32B Buy
10,690,678
+229,514
+2% +$29.6M 0.71% 22
2024
Q1
$1.38B Sell
10,461,164
-1,595,753
-13% -$197M 0.75% 17
2023
Q4
$1.31B Sell
12,056,917
-273,178
-2% -$28.4M 0.78% 19
2023
Q3
$1.27B Sell
12,330,095
-1,154,477
-9% -$124M 0.83% 15
2023
Q2
$1.56B Sell
13,484,572
-172,415
-1% -$19.6M 0.97% 12
2023
Q1
$1.45B Buy
13,656,987
+266,757
+2% +$28.8M 0.96% 13
2022
Q4
$1.49B Sell
13,390,230
-14,000,356
-51% -$1.43B 1.06% 10
2022
Q3
$2.36B Buy
27,390,586
+16,459,944
+151% +$1.47B 0.88% 15
2022
Q2
$997M Sell
10,930,642
-1,027,093
-9% -$91.1M 0.69% 20
2022
Q1
$981M Sell
11,957,735
-638,043
-5% -$50.3M 0.47% 42
2021
Q4
$965M Sell
12,595,778
-4,881,403
-28% -$389M 0.4% 51
2021
Q3
$1.31B Sell
17,477,181
-233,106
-1% -$17.7M 0.57% 27
2021
Q2
$1.38B Sell
17,710,287
-6,884,997
-28% -$512M 0.59% 23
2021
Q1
$1.81B Sell
24,595,284
-460,619
-2% -$34M 0.83% 15
2020
Q4
$1.96B Sell
25,055,903
-4,015,994
-14% -$307M 0.91% 12
2020
Q3
$2.3B Sell
29,071,897
-4,040,434
-12% -$316M 1.2% 10
2020
Q2
$2.44B Buy
33,112,331
+2,397,419
+8% +$180M 1.37% 7
2020
Q1
$2.26B Buy
30,714,912
+370,895
+1% +$29.1M 1.55% 7
2019
Q4
$2.63B Buy
30,344,017
+4,305,976
+17% +$354M 1.35% 7
2019
Q3
$2.09B Buy
26,038,041
+5,774
+0% +$463K 1.13% 8
2019
Q2
$2.08B Buy
26,032,267
+1,876,345
+8% +$144M 1.13% 7
2019
Q1
$1.92B Buy
24,155,922
+1,831,440
+8% +$137M 1.06% 8
2018
Q4
$1.63B Buy
22,324,482
+819,995
+4% +$57.9M 1.04% 9
2018
Q3
$1.46B Buy
21,504,487
+8,418,200
+64% +$536M 0.78% 11
2018
Q2
$758M Buy
13,086,287
+3,859,080
+42% +$218M 0.43% 42
2018
Q1
$480M Sell
9,227,207
-133,663
-1% -$7.22M 0.28% 91
2017
Q4
$503M Buy
9,360,870
+2,333,439
+33% +$129M 0.31% 80
2017
Q3
$429M Buy
7,027,431
+4,446,922
+172% +$270M 0.28% 99
2017
Q2
$158M Buy
2,580,509
+2,157,210
+510% +$131M 0.11% 249
2017
Q1
$25.7M Buy
423,299
+3,144
+0.7% +$191K 0.18% 142
2016
Q4
$23.6M Buy
420,155
+30,175
+8% +$1.77M 0.17% 153
2016
Q3
$23.2M Buy
389,980
+26,202
+7% +$1.53M 0.17% 156
2016
Q2
$20M Sell
363,778
-30,595
-8% -$1.63M 0.17% 166
2016
Q1
$19.9M Buy
394,373
+19,089
+5% +$935K 0.16% 161
2015
Q4
$18.9M Sell
375,284
-7,329
-2% -$370K 0.15% 169
2015
Q3
$18M Sell
382,613
-2,366
-0.6% -$126K 0.16% 165
2015
Q2
$20.9M Sell
384,979
-193,662
-33% -$10.9M 0.16% 161
2015
Q1
$31.7M Buy
578,641
+157,037
+37% +$8.89M 0.24% 112
2014
Q4
$22.8M Sell
421,604
-14,448
-3% -$805K 0.16% 174
2014
Q3
$24.7M Sell
436,052
-23,839
-5% -$1.34M 0.23% 102
2014
Q2
$25.4M Buy
459,891
+348
+0.1% +$19K 0.24% 110
2014
Q1
$24.9M Sell
459,543
-805,320
-64% -$41.7M 0.24% 102
2013
Q4
$60.4M Sell
1,264,863
-8,941
-0.7% -$409K 0.61% 31
2013
Q3
$57.9M Sell
1,273,804
-494,211
-28% -$22.6M 0.64% 29
2013
Q2
$78.2M Buy
+1,768,015
New +$79M 0.91% 17

Other funds holding MRK

Janus Henderson Group's MRK Position: Q1 2026 in Review

Janus Henderson Group increased its Merck (MRK) stake by 53% in Q1 2026, buying an estimated $115M and bringing the position to 2,880,199 shares worth $346M. The position accounts for 0.17% of the portfolio, ranked #136.

Janus Henderson Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.63B in Q4 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Janus Henderson Group held 2,880,199 shares of Merck worth $346M as of Q1 2026.
  • Janus Henderson Group bought 995,059 Merck shares in Q1 2026, an estimated $115M.
  • Merck made up 0.17% of Janus Henderson Group's portfolio in Q1 2026, its #136 holding.
  • Janus Henderson Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Janus Henderson Group's Merck position peaked at $2.63B in Q4 2019.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.